Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Feb 22 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS INC - ON FEBRUARY 20, BOARD OF
DIRECTORS OF
CO APPROVED PLAN OF LIQUIDATION AND DISSOLUTION OF COMPANY
* RUBIUS THERAPEUTICS INC - INTENDS TO CALL A SPECIAL
MEETING OF
STOCKHOLDERS TO SEEK APPROVAL OF THE PLAN OF DISSOLUTION
Source text: (https://bit.ly/3SioF2J)
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft